MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters

To control the coronavirus disease 2019 (COVID-19) pandemic and the emergence of different variants of concern (VoCs), novel vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed. In this study, we report the potent immunogenicity and efficacy induced in hamsters b...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudewijns, Robbert, Pérez, Patricia, Lázaro-Frías, Adrián, Van Looveren, Dominique, Vercruysse, Thomas, Thibaut, Hendrik Jan, Weynand, Birgit, Coelmont, Lotte, Neyts, Johan, Astorgano, David, Montenegro, Dolores, Puentes, Eugenia, Rodríguez, Esteban, Dallmeier, Kai, Esteban, Mariano, García-Arriaza, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966703/
https://www.ncbi.nlm.nih.gov/pubmed/35371064
http://dx.doi.org/10.3389/fimmu.2022.845969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966703/
https://www.ncbi.nlm.nih.gov/pubmed/35371064
http://dx.doi.org/10.3389/fimmu.2022.845969

Ejemplares similares